Navigation Links
Malaria Vaccine May Be 10 Years Away

Scientists in past centuries called the sickness by the Italian phrase 'malaria' — or 'bad air' — for the supposedly disease-bearing zephyrs wafting from swamps.

These days, scientists know malaria is spread by mosquitos. // And they say ill winds are buffeting their attempts to halt the spread of a disease that kills 1 million people a year, AP reports.

'We need to stress that the situation is bad. The number of deaths are rising, infections are rising,' said Pierre Druilhe, head of the biomedical unit at France's Pasteur Institute.

Scientists say it could take more than 10 years before a fully effective malaria vaccine is approved for use.

Hundreds of malaria experts gathered this week in Yaounde, Cameroon, for a conference on the disease. And while many scientists described solid recent advancements and reason for cautious optimism, others said the news isn't good for Africa.

While malaria has been all but eradicated in wealthy nations, scientists say they're hindered in Africa by twin hurdles: insecticide resistance in mosquitoes and drug resistance in the parasite.

Malaria is spread by mosquitoes and causes wracking pain, fever and, if left untreated, death. It kills more African children than any other disease, and is the leading cause of death of those under 5 in sub-Saharan Africa.

African poverty means few buyers for even relatively inexpensive insecticide-treated bed nets, so many companies shy away from producing them, scientists say. And anti-malarial drugs can be costly.

Malaria prevention is 'in trouble,' Brian Greenwood of the London School of Hygiene and Tropical Medicine said by telephone from Cameroon.

For Greenwood, the main problem is increased resistance to drugs, particularly the longtime mainstay, chloroquine, which is relatively cheap to produce in mass quantities.

Medical workers are turning to a new drug called artemisinin, derived fr om an herb indigenous to Asia. Drawing on lessons learned from treating HIV and AIDS, doctors are using artemisinin with other drugs. But production is slow and expensive.

'It's a plant that takes 18 months to grow. You can't just say that you need 20 million doses right now,' Greenwood said.

Without chloroquine and the insecticide DDT — which helped eradicate malaria in the United States and Europe but was ultimately believed by many to cause cancer and harm the environment — anti-malaria campaigners say they've lost two key weapons.

'It's pretty straightforward,' Druilhe said by telephone from Cameroon. 'We have today far less means to control malaria than 50 years ago.'

This means, he said, that 'the next decade will be a very bad decade.'

As for new insecticides, scientists say there are only pockets of resistance in the mosquitoes that carry malaria — at least so far.

'If you had in one place a high level of resistance to both drugs and insecticides, it would be a disaster,' Greenwood said.

Malaria, with over a half billion infections worldwide, is a major contributor to African poverty, scientists say, cutting billions from gross domestic product while weighing on health care systems.

But not all is calamity. Scientists say they've identified a resurgence in public and political interest in malaria over the past decade, a change they ascribe to greater media coverage and increased tourism in countries where the disease is a threat.

Malaria, Greenwood said, 'has dropped into the mainstream.'

Plus, scientists are increasingly banding together to study the problem — as they did this week in Cameroon — while philanthropists like Microsoft founder Bill Gates have donated huge amounts of money to fight the disease.

But Druilhe said more cash is needed. 'There's a need for the developing countries to put some pressure on the rich countries of t he north,' h said.

Related medicine news :

1. Malaria strikes Munger tribals
2. Sponging Cattle betters spraying in eradicating Malaria
3. Gene researchers make Malaria-resistant mosquito
4. More Treatment Options For Malaria
5. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
6. Jharkhand reports 13,000 Malaria cases
7. Researchers Discover Protein That Causes Malaria
8. Malarial gene ascertained
9. Artesunate Is Better For Malaria Than Quinine
10. New Strategies For Effective Treatment Of Malaria
11. Chloroquine and Primaquine combination Malarial drug for resistant parasites.
Post Your Comments:

(Date:12/1/2015)... ... December 01, 2015 , ... Baptist Medical Center ... and is the only hospital in the region providing what is known as ... transcatheter pacing patients were revealed recently at a medical conference and published in ...
(Date:12/1/2015)... MD (PRWEB) , ... December 01, 2015 , ... ... salmon identification tests to continue the expansion of the company’s growing product line ... – for Chinook (Oncorhynchus tshawytscha) and Sockeye (Oncorhynchus nerka) – allow InstantLabs to ...
(Date:12/1/2015)... New York, NY (PRWEB) , ... December 01, ... ... cause of non-traumatic limb amputations in the United States. Podiatrists are well aware ... (failure to adopt therapeutic behaviors) are often catastrophic contributors to diseases of the ...
(Date:12/1/2015)... CA (PRWEB) , ... December 01, 2015 , ... ... Health Center of Excellence (BHCOE) today announced that the organization has awarded Education ... San Francisco, with a Distinguished Award. The award celebrates exceptional special needs providers ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... for Effective Post-Affiliation Integration ,” addresses a main “pain point” for merging or ... anticipated results, once a deal is signed. This quick-read guidance suggests that ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... During the recent 2015 Transcatheter Cardiovascular ... CA , Medinol Ltd. continued to introduce ... a satellite symposium, "The BioNIR eDES: The Role ... a renowned physician panel discussed the key attributes ... Stent System and the Medinol eDES Coronary Stent ...
(Date:12/1/2015)... YORK , Dec. 1, 2015 Relmada Therapeutics, ... the treatment of chronic pain, announced today that the company ... will be held December 1-3 at the Luxe Sunset Boulevard ... Sergio Traversa , CEO of Relmada Therapeutics, will present on ... Eastern Time). . Please register at least ...
(Date:12/1/2015)... Dec. 1, 2015  InCarda Therapeutics, Inc. (InCarda), a ... of therapies for cardiovascular conditions via the inhalation route, ... in Australia . InCarda is planning ... Australia in the first half of ... medical centers in Adelaide and ...
Breaking Medicine Technology: